{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:17:20Z","timestamp":1781309840973,"version":"3.54.1"},"reference-count":36,"publisher":"Japanese Society for Bacteriology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nippon Saikingaku Zasshi","Nihon Saikingaku Zasshi","JAPANESE JOURNAL OF BACTERIOLOGY"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3412\/jsb.69.547","type":"journal-article","created":{"date-parts":[[2014,11,28]],"date-time":"2014-11-28T10:19:56Z","timestamp":1417169996000},"page":"547-555","source":"Crossref","is-referenced-by-count":3,"title":["Series of studies concerning group B streptococci with reduced penicillin susceptibility (PRGBS)"],"prefix":"10.3412","volume":"69","author":[{"given":"Kouji","family":"KIMURA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2014","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) American Academy of Pediatrics Committee on Infectious Disease, Committee on Fetus and Newborn. (1997): Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics <b>99<\/b>, 489\u2013496.","DOI":"10.1542\/peds.99.3.489"},{"key":"2","unstructured":"2) Baker, C.J. (2000): Group B Streptococcal Infections. p. 222\u2013237. In Stevens, D.L., Kaplan, E.L. (eds), Streptococcal infections. Clinical aspects, microbiology, and molecular pathogenesis, Oxford, England, Oxford University Press."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Banno, H., Kimura, K., Tanaka, Y., Kitanaka, H., Jin, W., Wachino, J., Yamada, K., Shibayama, K., Arakawa, Y. (2014): Characterization of multidrug-resistant group B streptococci with reduced penicillin susceptibility forming small non-\u03b2-hemolytic colonies on sheep blood agar plates. J. Clin. Microbiol. <b>52<\/b>, 2169\u20132171.","DOI":"10.1128\/JCM.00226-14"},{"key":"4","unstructured":"4) Center for Disease Control and Prevention. (2002): Prevention of perinatal group B streptococcal disease. MMWR, Morb. Mortal. Wkly. Rep. <b>51<\/b>, 1\u201322."},{"key":"5","unstructured":"5) Clinical and Laboratory Standards Institute. (2006): Performance standards for antimicrobial susceptibility testing; Sixteenth informational supplement M100-S16 <b>26<\/b>, 138\u2013140."},{"key":"6","unstructured":"6) Committee on Obstetric Practice. (1996): Prevention of early-onset group B streptococcal disease in newborns. Washington, D.C., American College of Obstetricians and Gynecologists."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Dahesh, S., Hensler, M.E., Van Sorge, N.M., Gertz, Jr., R.E., Schrag, S., Nizet, V., Beall, B.W. (2008): Point mutation in the group B streptococcal <i>pbp2x<\/i> gene conferring decreased susceptibility to \u03b2-lactam antibiotics. Antimicrob. Agents Chemother. <b>52<\/b>, 2915\u20132918.","DOI":"10.1128\/AAC.00461-08"},{"key":"8","unstructured":"8) Edwards, M.S., Baker, C.J. (2005): Group B streptococcal infections in elderly adults. Clin. Infect. Dis. <b>41<\/b>, 839\u2013847."},{"key":"9","unstructured":"9) European Committee on Antimicrobial Susceptibility Testing. (2014): Breakpoint tables for interpretation of MICs and zone diameters Version 4.0, valid from 2014-01-01."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Farley, M.M. (2001): Group B streptococcal disease in non pregnant adults. Clin. Infect. Dis. <b>33<\/b>, 556\u2013561.","DOI":"10.1086\/322696"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Farley, M.M., Harvey, R.C., Stull, T., Smith, J.D., Schuchat, A., Wenger, J.D., Stephens, D.S. (1993): A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N. Engl. J. Med. <b>328<\/b>, 1807\u20131811.","DOI":"10.1056\/NEJM199306243282503"},{"key":"12","unstructured":"12) Gaudreau, C., Lecours, R., Isma\u00efl, J., Gagnon, S., Jett\u00e9, L., Roger, M. (2009): Prosthetic hip joint infection with a <i>Streptococcus agalactiae<\/i> isolate not susceptible to penicillin G and ceftriaxone. J. Antimicrob. Chemother. <b>65<\/b>, 594\u2013595."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Heath, P.T., Balfour, G., Weisner, A.M., Efstratiou, A., Lamagni, T.L., Tighe, H., O\u2019Connell, L.A., Cafferkey, M., Verlander, N.Q., Nicoll, A., McCartney, A.C., PHLS Group B Streptococcus Working Group. (2004): Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet <b>363<\/b>, 292\u2013294.","DOI":"10.1016\/S0140-6736(03)15389-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Jackson, L.A., Hilsdon, R., Farley, M.M., Harrison, L.H., Reingold, A.L., Plikaytis, B.D., Wenger, J.D., Schuchat, A. (1995): Risk factors for group B streptococcal disease in adults. Ann. Intern. Med. <b>123<\/b>, 415\u2013420.","DOI":"10.7326\/0003-4819-123-6-199509150-00003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Johri, A.K., Paoletti, L.C., Glaser, P., Dua, M., Sharma, P.K., Grandi, G., Rappuoli, R. (2006): Group B <i>Streptococcus<\/i>: global incidence and vaccine development. Nat. Rev. Microbiol. <b>4<\/b>, 932\u2013942.","DOI":"10.1038\/nrmicro1552"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kimura, K., Matsubara, K., Yamamoto, G., Shibayama, K., Arakawa, Y. (2013): Active screening of group B streptococci with reduced penicillin susceptibility and altered serotype distribution, isolated from pregnant women in Kobe, Japan. Jpn. J. Infect. Dis. <b>66<\/b>, 158\u2013160.","DOI":"10.7883\/yoken.66.158"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kimura, K., Nagano, N., Nagano, Y., Suzuki, S., Wachino, J., Shibayama, K., Arakawa, Y. (2013): High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility. J. Antimicrob. Chemother. <b>68<\/b>, 539\u2013542.","DOI":"10.1093\/jac\/dks423"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kimura, K., Nagano, N., Nagano, Y., Wachino, J., Shibayama, K., Arakawa, Y. (2013): Ability of the VITEK<sup>\u00ae<\/sup> 2 system to detect group B streptococci with reduced penicillin susceptibility (PRGBS). J. Antimicrob. Chemother. <b>68<\/b>, 1442\u20131444.","DOI":"10.1093\/jac\/dkt008"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kimura, K., Nagano, N., Nagano, Y., Wachino, J., Suzuki, S., Shibayama, K., Arakawa, Y. (2011): Predominance of sequence type 1 group with serotype VI among group B streptococci with reduced penicillin susceptibility identified in Japan. J. Antimicrob. Chemother. <b>66<\/b>, 2460\u20132464.","DOI":"10.1093\/jac\/dkr352"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kimura, K., Nishiyama, Y., Shimizu, S., Wachino, J., Matsui, M., Suzuki, S., Yamane, K., Shibayama, K., Arakawa, Y. (2013): Screening for group B streptococci with reduced penicillin susceptibility (PRGBS) in clinical isolates obtained between 1977 and 2005. Jpn. J. Infect. Dis. <b>66<\/b>, 222\u2013225.","DOI":"10.7883\/yoken.66.222"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kimura, K., Suzuki, S., Wachino, J., Kurokawa, H., Yamane, K., Shibata, N., Nagano, N., Kato, H., Shibayama, K., Arakawa, Y. (2008): First molecular characterization of group B strepto cocci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. <b>52<\/b>, 2890\u20132897.","DOI":"10.1128\/AAC.00185-08"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kimura, K., Wachino, J., Kurokawa, H., Matsui, M., Suzuki, S., Yamane, K., Nagano, N., Shibayama, K., Arakawa, Y. (2013): High cephalosporin resistance due to amino acid substitutions in PBP1A and PBP2X in a clinical isolate of group B streptococcus. J. Antimicrob. Chemother. <b>68<\/b>, 1533\u20131536.","DOI":"10.1093\/jac\/dkt060"},{"key":"23","unstructured":"23) Kimura, K., Wachino, J., Kurokawa, H., Suzuki, S., Yamane, K., Shibata, N., Arakawa, Y. (2006): Emergence of penicillin-resistant group B streptococci. abstr. C2-1286. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kimura, K., Wachino, J., Kurokawa, H., Suzuki, S., Yamane, K., Shibata, N., Arakawa, Y. (2009): Practical disk diffusion test for detecting group B streptococcus with reduced penicillin susceptibility. J. Clin. Microbiol. <b>47<\/b>, 4154\u20134157.","DOI":"10.1128\/JCM.02063-08"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kimura, K., Yanagisawa, H., Wachino, J., Shibayama, K., Arakawa, Y. (2013): Rapid and reliable loop-mediated isothermal amplification method for detecting <i>Streptococcus agalactiae<\/i>. Jpn. J. Infect. Dis. <b>66<\/b>, 546\u2013548.","DOI":"10.7883\/yoken.66.546"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Longtin, J., Vermeiren, C., Shahinas, D., Tamber, G.S., McGeer, A., Low, D.E., Katz, K., Pillai, D.R. (2011): Novel mutations in a patient isolate of <i>Streptococcus agalactiae<\/i> with reduced penicillin susceptibility emerging after long term oral suppressive therapy. Antimicrob. Agents Chemother. <b>55<\/b>, 2983\u20132985.","DOI":"10.1128\/AAC.01243-10"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Murayama, S.Y., Seki, C., Sakata, H., Sunaoshi, K., Nakayama, E., Iwata, S., Sunakawa, K., Ubukata, K.; Invasive Streptococcal Disease Working Group. (2009): Capsular type and antibiotic resistance in <i>Streptococcus agalctiae<\/i> isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob. Agents Chemother. <b>53<\/b>, 2650\u20132653.","DOI":"10.1128\/AAC.01716-08"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Nagano, N., Kimura, K., Nagano, Y., Yakumaru, H., Arakawa, Y. (2009): Molecular characterization of group B streptococci with reduced penicillin susceptibility recurrently isolated from a sacral decubitus ulcer. J. Antimicrob. Chemother. <b>64<\/b>, 1326\u20131328.","DOI":"10.1093\/jac\/dkp374"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nagano, N., Nagano, Y., Kimura, K., Tamai, K., Yanagisawa, H., Arakawa, Y. (2008): Genetic heterogeneity in <i>pbp<\/i> genes among clinically isolated group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. <b>52<\/b>, 4258\u20134267.","DOI":"10.1128\/AAC.00596-08"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Nagano, N., Nagano, Y., Toyama, M., Kimura, K., Shibayama, K., Arakawa, Y. (2014): Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility. J. Clin. Microbiol. <b>52<\/b>, 3406\u20133410.","DOI":"10.1128\/JCM.01291-14"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Nagano, N., Nagano, Y., Toyama, M., Kimura, K., Tamura, T., Shibayama, K., Arakawa, Y. (2012): Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1. J. Antimicrob. Chemother. <b>67<\/b>, 849\u2013856.","DOI":"10.1093\/jac\/dkr546"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Schuchat, A. (1998): Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol Rev. <b>11<\/b>, 497\u2013513.","DOI":"10.1128\/CMR.11.3.497"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Schuchat, A. (1999): Group B streptococcus. Lancet <b>353<\/b>, 51\u201356.","DOI":"10.1016\/S0140-6736(98)07128-1"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Stoll, B.J., Hansen, N., Fanaroff, A.A., Wright, L.L., Carlo, W.A., Ehrenkranz, R.A., Lemons, J.A., Donovan, E.F., Stark, A.R., Tyson, J.E., Oh, W., Bauer, C.R., Korones, S.B., Shankaran, S., Laptook, A.R., Stevenson, D.K., Papile, L.A., Poole, W.K. (2002): Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N. Engl. J. Med. <b>347<\/b>, 240\u2013247.","DOI":"10.1056\/NEJMoa012657"},{"key":"35","unstructured":"35) Verani, J.R., McGee, L., Schrag, S.J., Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). (2010): Prevention of perinatal group B streptococcal disease\u2014revised guidelines from CDC, 2010. MMWR Recomm. Rep. <b>59(RR-10)<\/b>, 1\u201336."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Yamada, R., Kimura, K., Nagano, N., Nagano, Y., Suzuki, S., Jin, W., Wachino, J., Yamada, K., Shibayama, K., Arakawa, Y. (2014): Comparative analysis of penicillin-susceptible and non-susceptible isolates in group B Streptococci by multilocus sequence typing. Jpn. J. Infect. Dis. (in press)","DOI":"10.7883\/yoken.JJID.2014.387"}],"container-title":["Nippon Saikingaku Zasshi"],"original-title":["\u30da\u30cb\u30b7\u30ea\u30f3\u4f4e\u611f\u53d7\u6027B\u7fa4\u9023\u9396\u7403\u83cc\uff08Group B Streptococci with Reduced Penicillin Susceptibility, PRGBS\uff09\u306b\u95a2\u3059\u308b\u4e00\u9023\u306e\u7814\u7a76"],"language":"en","deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T18:23:05Z","timestamp":1566066185000},"score":1,"resource":{"primary":{"URL":"http:\/\/jlc.jst.go.jp\/DN\/JST.JSTAGE\/jsb\/69.547?lang=en&from=CrossRef&type=abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3412\/jsb.69.547","relation":{},"ISSN":["0021-4930","1882-4110"],"issn-type":[{"value":"0021-4930","type":"print"},{"value":"1882-4110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}